HFHui Feng

Hui Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hui Feng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Baorui Chu

    Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

    1 shared publication
  • Chao Wu

    Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

    1 shared publication
  • Fan Cao

    Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

    1 shared publication
  • Fengyang Lei

    Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School

    1 shared publication
  • Ke Hu

    The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, China

    1 shared publication
  • Shang Li

    Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University

    1 shared publication

Latest Publications

  • Open Access

    Apolipoprotein E drives microglia activation in the development of autoimmune uveitis through up-regulation of peptidyl prolyl isomerase F

    by Shuhao Zeng, Yakun Wang, Xianyang Liu, Hui Feng, Fan Cao, Baorui Chu, Chao Wu, Wei Fan, Ke Hu, Fengyang Lei, et al.

    Autoimmune uveitis (AU) is a category of sight-threatening diseases with different pathological causes. Transcriptomic analysis of patients with AU revealed a highly oxidative stress profile as well as an up-regulated apolipoprotein E ( APOE ) expression in their peripheral blood mononuclear cells (PBMCs). In addition, single-cell RNA sequencing of retinal microglia also identified an up-regulated expression of APOE in a murine model of experimental AU (EAU). Our results and others previously suggested that microglia are tightly associated with the development of AU. Meanwhile, although APOE has been reported to play a myriad of functions ranging from lipid metabolism to neural regeneration, little is known about its detailed mechanism in the development of AU. In this study, a murine EAU model was used to investigate the association between APOE , microglia, and EAU, and it is found that APOE is indispensable for EAU induction as APOE −/− mice failed to develop EAU. In vitro studies using microglial cells further demonstrated that APOE is positively corelated with microglial inflammation, which could be reversed by knocking down APOE using short hairpin RNA. Proteomic analysis indicated that APOE -mediated microglial activation relies on reactive oxygen species (ROS) pathway, through peptidyl prolyl isomerase F ( PPIF ), which was further verified in PBMCs derived from patients with AU. Supplementation of PPIF reverses APOE deficiency–caused ROS activation in vitro. In addition, Adeno-associated virus-mediated overexpression of PPIF exacerbated EAU phenotype, suggesting its important role in driving uveitis initiation. These results provide an understanding of APOE and PPIF in the pathogenesis of uveitis.


  • Open Access

    Leucocytoclastic Vasculitis Presenting as Bilateral Ulcerative Keratitis: A Case Report

    by Hui Feng, Shang Li, Ying Jie

    Introduction: Small artery disease caused by neutrophils and immune-mediated is known as leucocytoclastic vasculitis (LCV). Clinically, it manifests as palpable, asymptomatic purpuric papules on the limbs. Ocular manifestation is rare. Here, we describe a case of peripheral ulcerative keratitis (PUK) associated with LCV. Case presentation: A 59-year-old man was referred to the hospital with blurred vision due to corneal perforation in his left eye. He complained of itchy nodules on his hands and lower legs for 15 years and the skin biopsy of the back of his hand revealed LCV 6 years ago, which suggested erythema elevatum diutinum. The patient was under treatment with anti-inflammatory and immunosuppressive drugs and physical features of LCV seen in him included erythema on his hands and legs. After receiving conjunctival flap covering surgery, the corneal perforation was resolved. Conjunctival flaps covered cornea that limited his vision to hand motion. Six months later, he was referred to our clinic again because of pain, redness, photophobia, and tearing in the right eye, presenting with PUK. Necrotic tissue was removed during surgery, which also included a conjunctival flap covering procedure. Following surgery, the symptoms were reduced, and the postoperative eye condition remained stable. Conclusion: To our knowledge, it is the first case of PUK secondary to LCV which was diagnosed 6 years ago. This case demonstrates that PUK associated with LCV can be successfully treated by surgical interventions.